These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 22373583)
1. Serum HE4 as a diagnostic and prognostic marker for lung cancer. Iwahori K; Suzuki H; Kishi Y; Fujii Y; Uehara R; Okamoto N; Kobayashi M; Hirashima T; Kawase I; Naka T Tumour Biol; 2012 Aug; 33(4):1141-9. PubMed ID: 22373583 [TBL] [Abstract][Full Text] [Related]
2. The Application Value of Serum HE4 in the Diagnosis of Lung Cancer. Wang Y; Wang Z; Ding Y; Sun F; Ding X Asian Pac J Cancer Prev; 2019 Aug; 20(8):2405-2407. PubMed ID: 31450913 [TBL] [Abstract][Full Text] [Related]
3. Evaluating the expression and diagnostic value of human epididymis protein 4 (HE4) in small cell lung cancer. Wang X; Fan Y; Wang J; Wang H; Liu W Tumour Biol; 2014 Jul; 35(7):6847-53. PubMed ID: 25051914 [TBL] [Abstract][Full Text] [Related]
4. Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer. Mo D; He F Clin Lab; 2018 Sep; 64(9):1421-1428. PubMed ID: 30274019 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic Performance of Serum Human Epididymis Protein 4 (HE4) for Prediction of Malignancy in Ovarian Masses. Dewan R; Dewan A; Jindal M; Bhardawaj M Asian Pac J Cancer Prev; 2019 Apr; 20(4):1103-1108. PubMed ID: 31030480 [TBL] [Abstract][Full Text] [Related]
6. Serum level of HE4 is closely associated with pulmonary adenocarcinoma progression. Yamashita S; Tokuishi K; Moroga T; Yamamoto S; Ohbo K; Miyahara S; Yoshida Y; Yanagisawa J; Hamatake D; Hiratsuka M; Yoshinaga Y; Shiraishi T; Iwasaki A; Kawahara K Tumour Biol; 2012 Dec; 33(6):2365-70. PubMed ID: 23001907 [TBL] [Abstract][Full Text] [Related]
7. Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. Bandiera E; Romani C; Specchia C; Zanotti L; Galli C; Ruggeri G; Tognon G; Bignotti E; Tassi RA; Odicino F; Caimi L; Sartori E; Santin AD; Pecorelli S; Ravaggi A Cancer Epidemiol Biomarkers Prev; 2011 Dec; 20(12):2496-506. PubMed ID: 22028406 [TBL] [Abstract][Full Text] [Related]
8. HE4 combined with CA125: favorable screening tool for ovarian cancer. Ghasemi N; Ghobadzadeh S; Zahraei M; Mohammadpour H; Bahrami S; Ganje MB; Rajabi S Med Oncol; 2014 Jan; 31(1):808. PubMed ID: 24323399 [TBL] [Abstract][Full Text] [Related]
9. Human epididymal protein 4 and its combined detection show good diagnostic value in lung cancer: A retrospective study. Wu L; Chen X; Peng T; Tang E; Bai W; Chen L Int J Biol Markers; 2024 Jun; 39(2):141-148. PubMed ID: 38619974 [TBL] [Abstract][Full Text] [Related]
10. Evaluating the clinical significance of serum HE4 levels in lung cancer and pulmonary tuberculosis. Liu W; Yang J; Chi PD; Zheng X; Dai SQ; Chen H; Xu BL; Liu WL Int J Tuberc Lung Dis; 2013 Oct; 17(10):1346-53. PubMed ID: 24025389 [TBL] [Abstract][Full Text] [Related]
11. Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response. Hamed EO; Ahmed H; Sedeek OB; Mohammed AM; Abd-Alla AA; Abdel Ghaffar HM Diagn Pathol; 2013 Jan; 8():11. PubMed ID: 23343214 [TBL] [Abstract][Full Text] [Related]
12. Human epididymis protein 4, a novel potential biomarker for diagnostic and prognosis monitoring of lung cancer. Zhang T; Chu L; Tan W; Ye C; Dong H Clin Respir J; 2024 May; 18(5):e13774. PubMed ID: 38742362 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients. Fan J; Yu H; Lv Y; Yin L Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622 [TBL] [Abstract][Full Text] [Related]
14. The differential diagnostic value and clinical significance of serum HE4 in ovarian disease with elevated CA125. Li W; Wang D Arch Gynecol Obstet; 2020 May; 301(5):1219-1225. PubMed ID: 32266526 [TBL] [Abstract][Full Text] [Related]
17. Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer. Nagy B; Bhattoa HP; Steiber Z; Csobán M; Szilasi M; Méhes G; Müller M; Lázár J; Kappelmayer J; Antal-Szalmás P Clin Chem Lab Med; 2014 Nov; 52(11):1639-48. PubMed ID: 24829194 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of CA125 and HE4 in ovarian carcinoma patients and the effect of confounders on their serum levels. Ahmed AA; Abdou AM Curr Probl Cancer; 2019 Oct; 43(5):450-460. PubMed ID: 30670303 [TBL] [Abstract][Full Text] [Related]
19. Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer. Korkmaz ET; Koksal D; Aksu F; Dikmen ZG; Icen D; Maden E; Onder S; Akbiyik F; Emri S Clin Biochem; 2018 Aug; 58():15-19. PubMed ID: 29729229 [TBL] [Abstract][Full Text] [Related]
20. The clinical value of the combined detection of sEGFR, CA125 and HE4 for epithelial ovarian cancer diagnosis. Li Y; Wang ZC; Luo L; Mu CY; Xu J; Feng Q; Li SB; Gu B; Ma P; Lan T Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):604-610. PubMed ID: 32016961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]